← Back to screener

Surgery Partners, Inc. SGRY

Rank #1446 · Nasdaq · $3.0B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
48.1
P/E
-255.1
P/B
1.70
ROE
-0.7%
Op. Margin
12.0%
Debt Ratio
341%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★☆☆
Average

P/E -255.1x, P/B 1.70x. Ranks in the top 48% of the universe.

Profitability ★★☆☆☆
Average

ROE -0.7%. Ranks in the top 53% of the universe.

Safety ★☆☆☆☆
Weak

Debt ratio 341%. Ranks in the top 74% of the universe. Above 200% signals meaningful leverage risk.

Growth ★★★☆☆
Good

Revenue growth of 8.0% year over year. Ranks in the top 40% of the universe.

Valuation is the relative strength · Safety is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2015$0.3B$0.1B$-0.0B$-0.3B20.5-804
2016$0.4B$0.1B$-0.1B$-0.0B12.6-52345
2017–––$0.7B–606
2018$1.1B$0.1B$-0.2B$0.7B6.8606
2019$1.8B$0.1B$-0.2B$0.4B4.41056
2020$1.8B$0.1B$-0.2B$0.3B4.41591
2021$1.8B$0.2B$-0.1B$0.1B12.94583
2022$1.9B$0.2B$-0.1B$1.1B9.8462
2023$2.2B$0.3B$-0.1B$2.0B13.6234
2024$2.5B$0.3B$-0.1B$2.0B13.6246
2025$2.7B$0.3B$-0.0B$1.8B12.0341

← See the full screener